Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a ...
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
“The UCI takes a bold and necessary stance by banning the repeated use of carbon-monoxide inhalation on medical grounds,” UCI ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...
HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.
PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...
People who have struggled with their weight have found relief with a new drug. But then their weight loss ground to a halt. A ...
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results